Try our beta test site

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

This study has been completed.
Information provided by (Responsible Party):
Sterna Biologicals GmbH & Co. KG Identifier:
First received: April 11, 2012
Last updated: April 28, 2014
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)